Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Aragen Invests US$3 Million to Construct New Manufacturing Facility in India
Aragen invests US$3 million to open new stateoftheart formulations manufacturing facility in India This stateoftheart facility spans over 12,000 square
Avid Bioservices Invests US$400 million to Construct New Cell and Gene Manufacturing Facility in California, USA
Avid Bioservices is investing approximately US$400 million to construct a new worldclass cell and gene therapy development and manufacturing facility in California, USA
OBiO Technology Plans to Open New Production Facility in Shanghai, China
OBiO Technology unveiled to construct new stateoftheart GMP production facility, IntelliM for developing advanced therapies in Shanghai, China
Aragen Invests US$30 million to Construct Bio-manufacturing Site in India
Aragen plans to invest US$30 million to setup a new biologics manufacturing facility in Bangalore, India
BioSpark Labs Invests US$6 million to Open New Facility in Atlanta, USA
BioSpark Labs has invested US$6 million facility to support life sciences research in the Atlanta, USA
North California State University Unveils New Integrative Sciences Building in USA
North California State University plans for the construction of the Integrative Sciences Building on its Main Campus in the USA
Almac Group Invests US$ 84.7 million (£80 million) to Open Manufacturing Facility in Ireland
The Almac Group plans to invest US$ 847 million 80 million in building new extensive manufacturing, production, and diagnostic laboratory facilities in Craigavon, Northern Ireland
University of Pittsburgh Plans to Construct Bio manufacturing Centre in USA
The Universitys plan to construct a stateoftheart life sciences facility This centre will serve as a hub for life sciences and biotechnology research
Roswell Park Comprehensive Cancer Centre Invests US$98 million to Open Cell and Gene Therapy Hub in New York, USA
Roswell Park Comprehensive Cancer Centre invests US$98 million to open cell and gene therapy manufacturing facility in USA
Syngene Invests US$9.5 (INR 788 crores) to Open New Facility in India
Syngene with an investment of US$95 INR 788 crores plans to build new stateoftheart research laboratories in Hyderabad, India This will be an extension to its existing research campus
